These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 21152691)
1. [Overcoming of radiation resistances]. Friesen C; Hormann I; Roscher M; Bacher S; Miltner E Nuklearmedizin; 2010; 49 Suppl 1():S31-6. PubMed ID: 21152691 [TBL] [Abstract][Full Text] [Related]
2. Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells. Friesen C; Glatting G; Koop B; Schwarz K; Morgenstern A; Apostolidis C; Debatin KM; Reske SN Cancer Res; 2007 Mar; 67(5):1950-8. PubMed ID: 17332322 [TBL] [Abstract][Full Text] [Related]
3. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond]. Teh BS; Paulino A; Butler EB Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628 [TBL] [Abstract][Full Text] [Related]
4. Proton radiation in the management of localized cancer. Paganetti H; Kooy H Expert Rev Med Devices; 2010 Mar; 7(2):275-85. PubMed ID: 20214431 [TBL] [Abstract][Full Text] [Related]
5. Targeting base excision repair as a sensitization strategy in radiotherapy. Vens C; Begg AC Semin Radiat Oncol; 2010 Oct; 20(4):241-9. PubMed ID: 20832016 [TBL] [Abstract][Full Text] [Related]
6. [Biomodulation and radiotherapy]. Bourhis J; Lartigau E Cancer Radiother; 2000 Nov; 4 Suppl 1():128s-133s. PubMed ID: 11194950 [TBL] [Abstract][Full Text] [Related]
7. Microdosimetric basis of individualized cancer radiotherapy by radionuclides including Auger effect and the photon activation approach. Booz J Strahlentherapie; 1984 Dec; 160(12):745-54. PubMed ID: 6393457 [No Abstract] [Full Text] [Related]
8. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines. Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875 [TBL] [Abstract][Full Text] [Related]
9. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Chistiakov DA; Voronova NV; Chistiakov PA Acta Oncol; 2008; 47(5):809-24. PubMed ID: 18568480 [TBL] [Abstract][Full Text] [Related]
10. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance. Zhu Y; Hu J; Hu Y; Liu W Cancer Treat Rev; 2009 Nov; 35(7):590-6. PubMed ID: 19635647 [TBL] [Abstract][Full Text] [Related]
11. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. An J; Chervin AS; Nie A; Ducoff HS; Huang Z Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121 [TBL] [Abstract][Full Text] [Related]
12. Comparison of different classes of radionuclides for potential use in radioimmunotherapy. Karagiannis TC Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582 [TBL] [Abstract][Full Text] [Related]
13. TCP and NTCP: a basic introduction. Baumann M; Petersen C Rays; 2005; 30(2):99-104. PubMed ID: 16294901 [TBL] [Abstract][Full Text] [Related]